Adapted physical activity and cardiac coherence in hematologic patients (APACCHE): study protocol for a randomized controlled trial
Open Access
- 14 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Sports Science, Medicine and Rehabilitation
- Vol. 12 (1), 1-11
- https://doi.org/10.1186/s13102-020-00170-3
Abstract
Background Hematologic malignancies and their treatments are recognized for their significant long-term adverse effects on health-related quality of life. As a part of cancer treatment, physical exercise is known to improve physical functioning, but there are still questions regarding its impact on psychological and emotional functioning. Nonetheless, heart rate variability biofeedback (HRVB) is recognized for its positive effects on autonomic nervous system balance and emotional self-regulation. The Adapted Physical Activity and Cardiac Coherence in Hematologic Patients (APACCHE) protocol is a randomized, controlled superiority trial designed to evaluate the effects of HRBV training combined with an adaptive physical activity (APA) program compared to APA alone on the post-treatment quality of life of adult hematologic patients. Methods Seventy patients aged 18-70 years, with various forms of hematological malignancies, in post-treatment remission within six months prior to beginning the study and who have been prescribed APA by a hematologist, will be randomly allocated in a 1:1 ratio to two 12-week treatment groups: HRVB + APA versus APA alone. APA sessions will consist of aerobic and resistance training for 1-h twice weekly. The HRVB training will consist of controlled breathing exercises with biofeedback of heart rate variability for 10 sessions and will include a daily home-based practice. The primary outcome will be to evaluate health-related quality of life (QLQ-C30, SF-36). The secondary outcomes will be to evaluate fatigue (MFI-20); anxiety and depression (HADS); clinical status with blood pressure, progression-free survival, overall survival, and body mass index; heart rate variability level and cardiac coherence score. All of these assessments will be evaluated initially (T1), 6 weeks after (T2), at the end of the 12 weeks (T3), and then at a 12-week post-intervention follow-up (T4). Discussion To our knowledge, this is the first protocol to investigate the additional value of HRVB on physical exercise. In addition, there has been no study previously published about HRVB in hematologic patients. We hypothesize that overall quality of life and psychological and physical functioning will be improved, potentially offering a better understanding of supportive cancer care in hematology and inferring new perspectives in psychophysiological research in cancer.Funding Information
- Reunion Island South University Hospital
- Réunion Region
- IRISSE Laboratory
- Regional Public Health Agency
This publication has 72 references indexed in Scilit:
- Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30Bone Marrow Transplantation, 2011
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsBlood, 2011
- Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE projectBlood, 2010
- Cardiac side-effects of cancer chemotherapyInternational Journal of Cardiology, 2010
- Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-AnalysisBiological Psychiatry, 2010
- Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literaturePsycho‐Oncology, 2008
- Physical exercise as adjuvant therapy for patients undergoing hematopoietic stem cell transplantationBone Marrow Transplantation, 2007
- Physical Function in Patients with Cancer: Psychometric Characteristics and Clinical Usefulness of a Physical Performance Test BatteryJournal of Pain and Symptom Management, 2002
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992